cross-posted from: https://lemm.ee/post/64477597
Regeneron is to pay $256 million in cash to acquire “substantially all” of 23andMe’s assets, including its massive biobank of around 15 million customer genetic samples and data.
cross-posted from: https://lemm.ee/post/64477597
Regeneron is to pay $256 million in cash to acquire “substantially all” of 23andMe’s assets, including its massive biobank of around 15 million customer genetic samples and data.
it was part of a study some research team was doing on bi men (lol back when I still thought I was bi).